has been named among the world's 150 most promising digital health startups by US-based business analytics firm CB Insights
The selection, which included another Indian company, Pharmeasy, came from an analysis of over 8,000 startups worldwide.
In a period where the digital health sector is gaining prime importance due to the ongoing COVID-19 pandemic, Qure.ai's recognition underscores the value of its AI-led solutions, specifically those facilitating quick medical tests and diagnostics.
The startup recently made headlines for an AI solution identifying high-risk COVID-19 patients using chest X-rays and CT scans. This chest X-ray AI tool, qXR, is currently utilized in 28 countries.
Founded in 2016 by Dr. Pooja Rao and Prashant Warier, Qure.ai has recently raised approximately $16 million from Sequoia India and MassMutual Ventures Southeast Asia.
This global recognition from CB Insights bodes well for Qure.ai, as India's health-tech industry is projected to reach $372 billion by 2022 and is expected to generate 40 million jobs by 2030, according to Invest India.